Zynex, Inc. (ZYXI) Granted FDA Clearance for Blood Volume Monitor
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Zynex, Inc. (ZYXI) Tops Q4 EPS by 1c, Revenues Beat; Offers Q1 & FY20 Revenue Guidance Above Consensus
February 27, 2020 4:50 PM ESTZynex, Inc. (NASDAQ: ZYXI) reported Q4 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $14.2 million versus the consensus estimate of $13.77 million.
2019 Fourth Quarter
Revenue increased 52% year over year to $14.2 millionOrders increased 129%Net income of $2.9 million; Diluted EPS $0.09Adjusted EBITDA increased 30% to $4.1 millionFourteenth consecutive quarter of positive net incomeThomas Sandgaard, CEO said: "In the fourth quarter, we posted revenue of $14.2... More
Zynex Inc. (ZYXI) PT Raised to $19.75 at B.Riley/FBR
February 21, 2020 10:48 AM ESTB.Riley/FBR analyst Marc Wiesenberger raised the price target on Zynex Inc. (NASDAQ: ZYXI) to $19.75 (from $12.00) while maintaining a Buy rating.... More
